Ross Cole, MD
Hand Surgery · Buffalo, NYNPI 1962865196
Payments from drug & device makers
What this record shows
Prodigy Surgical Distribution, Inc. accounts for 61.3% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $1,261 and has fallen 67.1% since, to $415 in 2025. That places this record below the midpoint for hand surgery clinicians in NY, where the typical reported total is $2,198.
Across 27 payments — averaging $85.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Prodigy Surgical Distribution, Inc.$1K
- Axogen$461
- Smith+Nephew$143
- Stryker$96
- Skeletal Dynamics Inc$76
- Endo Pharmaceuticals Inc.$35
- plus $86 from 4 others
What the payments were for
- Food & beverage$1,11548%
- Education$1,20052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Prodigy Surgical Distribution, Inc. | 3 | $1,418 |
| Axogen | 9 | $461 |
| Smith+Nephew | 3 | $143 |
| Stryker | 4 | $96 |
| Skeletal Dynamics Inc | 2 | $76 |
| Endo Pharmaceuticals Inc. | 2 | $35 |
| Endo USA, Inc. | 1 | $28 |
| Bioventus LLC | 1 | $23 |
| Amgen | 1 | $21 |
| Avanos Medical | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,315 in reported general payments places this provider in the 50th percentile of 178 hand surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 16 | $717 |
| Meloxicam | 42 | $155 |
Paid to pharmacies, not to this prescriber.
Other hand surgery in Buffalo
- Scott WolfeNy$251K
- Nader PaksimaNew York$171K
- Peter SteinGreat Neck$131K
- Michael HausmanNew York$128K
- Otis BarronNew York$122K
- Kevin SetterEast Syracuse$118K
- Nathan EverdingSyracuse$98K
- David TuckmanGreat Neck$96K
- Dan ZlotolowNew York$91K
- Andrew GreenbergGreat Neck$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.